nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—ALB—multiple sclerosis	0.181	1	CbGaD
Mycophenolate mofetil—ABCG2—Cladribine—multiple sclerosis	0.0579	0.123	CbGbCtD
Mycophenolate mofetil—ABCG2—Mitoxantrone—multiple sclerosis	0.0422	0.0894	CbGbCtD
Mycophenolate mofetil—SLCO1B3—Methotrexate—multiple sclerosis	0.038	0.0805	CbGbCtD
Mycophenolate mofetil—ABCC2—Dexamethasone—multiple sclerosis	0.0242	0.0513	CbGbCtD
Mycophenolate mofetil—ALB—Prednisone—multiple sclerosis	0.0242	0.0512	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Methotrexate—multiple sclerosis	0.0221	0.0469	CbGbCtD
Mycophenolate mofetil—ABCG2—Dexamethasone—multiple sclerosis	0.0219	0.0463	CbGbCtD
Mycophenolate mofetil—ABCB1—Methylprednisolone—multiple sclerosis	0.0209	0.0442	CbGbCtD
Mycophenolate mofetil—ABCC2—Methotrexate—multiple sclerosis	0.0195	0.0412	CbGbCtD
Mycophenolate mofetil—CYP3A4—Fingolimod—multiple sclerosis	0.0194	0.0411	CbGbCtD
Mycophenolate mofetil—ABCG2—Methotrexate—multiple sclerosis	0.0176	0.0372	CbGbCtD
Mycophenolate mofetil—ABCB1—Mitoxantrone—multiple sclerosis	0.0152	0.0322	CbGbCtD
Mycophenolate mofetil—ABCB1—Betamethasone—multiple sclerosis	0.0136	0.0287	CbGbCtD
Mycophenolate mofetil—ABCB1—Prednisolone—multiple sclerosis	0.0134	0.0283	CbGbCtD
Mycophenolate mofetil—ABCB1—Prednisone—multiple sclerosis	0.0126	0.0268	CbGbCtD
Mycophenolate mofetil—CYP3A4—Methylprednisolone—multiple sclerosis	0.0125	0.0265	CbGbCtD
Mycophenolate mofetil—CYP3A5—Dexamethasone—multiple sclerosis	0.0121	0.0257	CbGbCtD
Mycophenolate mofetil—ALB—Methotrexate—multiple sclerosis	0.0121	0.0257	CbGbCtD
Mycophenolate mofetil—CYP2C8—Dexamethasone—multiple sclerosis	0.0117	0.0247	CbGbCtD
Mycophenolate mofetil—CYP3A4—Triamcinolone—multiple sclerosis	0.00948	0.0201	CbGbCtD
Mycophenolate mofetil—CYP3A4—Mitoxantrone—multiple sclerosis	0.00912	0.0193	CbGbCtD
Mycophenolate mofetil—CYP3A4—Betamethasone—multiple sclerosis	0.00813	0.0172	CbGbCtD
Mycophenolate mofetil—CYP3A4—Prednisolone—multiple sclerosis	0.00802	0.017	CbGbCtD
Mycophenolate mofetil—ABCB1—Dexamethasone—multiple sclerosis	0.00789	0.0167	CbGbCtD
Mycophenolate mofetil—CYP3A4—Prednisone—multiple sclerosis	0.00758	0.016	CbGbCtD
Mycophenolate mofetil—ABCB1—Methotrexate—multiple sclerosis	0.00634	0.0134	CbGbCtD
Mycophenolate mofetil—CYP3A4—Dexamethasone—multiple sclerosis	0.00473	0.01	CbGbCtD
Mycophenolate mofetil—IMPDH1—retina—multiple sclerosis	0.000776	0.0576	CbGeAlD
Mycophenolate mofetil—CES2—retina—multiple sclerosis	0.00071	0.0527	CbGeAlD
Mycophenolate mofetil—IMPDH2—medulla oblongata—multiple sclerosis	0.000565	0.0419	CbGeAlD
Mycophenolate mofetil—IMPDH1—medulla oblongata—multiple sclerosis	0.000561	0.0417	CbGeAlD
Mycophenolate mofetil—IMPDH2—midbrain—multiple sclerosis	0.000516	0.0383	CbGeAlD
Mycophenolate mofetil—CES2—medulla oblongata—multiple sclerosis	0.000513	0.0381	CbGeAlD
Mycophenolate mofetil—IMPDH1—midbrain—multiple sclerosis	0.000513	0.0381	CbGeAlD
Mycophenolate mofetil—IMPDH2—spinal cord—multiple sclerosis	0.000504	0.0374	CbGeAlD
Mycophenolate mofetil—IMPDH1—spinal cord—multiple sclerosis	0.0005	0.0372	CbGeAlD
Mycophenolate mofetil—CES2—midbrain—multiple sclerosis	0.000469	0.0348	CbGeAlD
Mycophenolate mofetil—CES2—spinal cord—multiple sclerosis	0.000458	0.034	CbGeAlD
Mycophenolate mofetil—IMPDH2—nervous system—multiple sclerosis	0.000424	0.0315	CbGeAlD
Mycophenolate mofetil—IMPDH1—nervous system—multiple sclerosis	0.000422	0.0313	CbGeAlD
Mycophenolate mofetil—IMPDH2—central nervous system—multiple sclerosis	0.000409	0.0303	CbGeAlD
Mycophenolate mofetil—IMPDH1—central nervous system—multiple sclerosis	0.000406	0.0301	CbGeAlD
Mycophenolate mofetil—IMPDH2—cerebellum—multiple sclerosis	0.000399	0.0296	CbGeAlD
Mycophenolate mofetil—IMPDH1—cerebellum—multiple sclerosis	0.000397	0.0295	CbGeAlD
Mycophenolate mofetil—CES2—nervous system—multiple sclerosis	0.000386	0.0286	CbGeAlD
Mycophenolate mofetil—CES2—central nervous system—multiple sclerosis	0.000371	0.0276	CbGeAlD
Mycophenolate mofetil—CES2—cerebellum—multiple sclerosis	0.000363	0.0269	CbGeAlD
Mycophenolate mofetil—IMPDH2—brain—multiple sclerosis	0.000324	0.0241	CbGeAlD
Mycophenolate mofetil—IMPDH1—brain—multiple sclerosis	0.000322	0.0239	CbGeAlD
Mycophenolate mofetil—CES1—nervous system—multiple sclerosis	0.000318	0.0236	CbGeAlD
Mycophenolate mofetil—CES1—central nervous system—multiple sclerosis	0.000306	0.0227	CbGeAlD
Mycophenolate mofetil—CES2—brain—multiple sclerosis	0.000295	0.0219	CbGeAlD
Mycophenolate mofetil—CES1—brain—multiple sclerosis	0.000243	0.018	CbGeAlD
Mycophenolate mofetil—ABCG2—medulla oblongata—multiple sclerosis	0.000201	0.0149	CbGeAlD
Mycophenolate mofetil—ABCG2—midbrain—multiple sclerosis	0.000184	0.0136	CbGeAlD
Mycophenolate mofetil—ABCG2—spinal cord—multiple sclerosis	0.000179	0.0133	CbGeAlD
Mycophenolate mofetil—ALB—brain—multiple sclerosis	0.000169	0.0125	CbGeAlD
Mycophenolate mofetil—ABCG2—cerebellum—multiple sclerosis	0.000142	0.0105	CbGeAlD
Mycophenolate mofetil—ABCB1—retina—multiple sclerosis	0.000137	0.0102	CbGeAlD
Mycophenolate mofetil—CYP2C8—brain—multiple sclerosis	0.000119	0.0088	CbGeAlD
Mycophenolate mofetil—ABCG2—brain—multiple sclerosis	0.000115	0.00856	CbGeAlD
Mycophenolate mofetil—CYP3A4—nervous system—multiple sclerosis	0.000105	0.0078	CbGeAlD
Mycophenolate mofetil—CYP3A4—central nervous system—multiple sclerosis	0.000101	0.00751	CbGeAlD
Mycophenolate mofetil—ABCB1—medulla oblongata—multiple sclerosis	9.9e-05	0.00735	CbGeAlD
Mycophenolate mofetil—ABCB1—midbrain—multiple sclerosis	9.05e-05	0.00672	CbGeAlD
Mycophenolate mofetil—ABCB1—spinal cord—multiple sclerosis	8.83e-05	0.00655	CbGeAlD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	7.52e-05	0.000759	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.47e-05	0.000754	CbGpPWpGaD
Mycophenolate mofetil—CES1—NRF2 pathway—TGFB1—multiple sclerosis	7.45e-05	0.000752	CbGpPWpGaD
Mycophenolate mofetil—Shock—Methylprednisolone—multiple sclerosis	7.45e-05	0.000319	CcSEcCtD
Mycophenolate mofetil—ABCB1—nervous system—multiple sclerosis	7.44e-05	0.00552	CbGeAlD
Mycophenolate mofetil—Hepatobiliary disease—Methotrexate—multiple sclerosis	7.43e-05	0.000318	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Methylprednisolone—multiple sclerosis	7.42e-05	0.000318	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Dexamethasone—multiple sclerosis	7.41e-05	0.000318	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Betamethasone—multiple sclerosis	7.41e-05	0.000318	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Methotrexate—multiple sclerosis	7.41e-05	0.000317	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Mitoxantrone—multiple sclerosis	7.41e-05	0.000317	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Prednisolone—multiple sclerosis	7.41e-05	0.000317	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Triamcinolone—multiple sclerosis	7.4e-05	0.000317	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Prednisone—multiple sclerosis	7.39e-05	0.000317	CcSEcCtD
Mycophenolate mofetil—Nausea—Azathioprine—multiple sclerosis	7.39e-05	0.000316	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Methylprednisolone—multiple sclerosis	7.39e-05	0.000316	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Methylprednisolone—multiple sclerosis	7.35e-05	0.000315	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Prednisone—multiple sclerosis	7.34e-05	0.000315	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Triamcinolone—multiple sclerosis	7.33e-05	0.000314	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Methotrexate—multiple sclerosis	7.33e-05	0.000314	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Methylprednisolone—multiple sclerosis	7.32e-05	0.000313	CcSEcCtD
Mycophenolate mofetil—Convulsion—Betamethasone—multiple sclerosis	7.31e-05	0.000313	CcSEcCtD
Mycophenolate mofetil—Convulsion—Dexamethasone—multiple sclerosis	7.31e-05	0.000313	CcSEcCtD
Mycophenolate mofetil—Hypertension—Dexamethasone—multiple sclerosis	7.28e-05	0.000312	CcSEcCtD
Mycophenolate mofetil—Hypertension—Betamethasone—multiple sclerosis	7.28e-05	0.000312	CcSEcCtD
Mycophenolate mofetil—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	7.25e-05	0.000731	CbGpPWpGaD
Mycophenolate mofetil—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	7.21e-05	0.000728	CbGpPWpGaD
Mycophenolate mofetil—Asthenia—Mitoxantrone—multiple sclerosis	7.21e-05	0.000309	CcSEcCtD
Mycophenolate mofetil—Myalgia—Betamethasone—multiple sclerosis	7.18e-05	0.000308	CcSEcCtD
Mycophenolate mofetil—Myalgia—Dexamethasone—multiple sclerosis	7.18e-05	0.000308	CcSEcCtD
Mycophenolate mofetil—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	7.17e-05	0.000723	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—central nervous system—multiple sclerosis	7.16e-05	0.00532	CbGeAlD
Mycophenolate mofetil—Anxiety—Dexamethasone—multiple sclerosis	7.15e-05	0.000306	CcSEcCtD
Mycophenolate mofetil—Anxiety—Betamethasone—multiple sclerosis	7.15e-05	0.000306	CcSEcCtD
Mycophenolate mofetil—Discomfort—Betamethasone—multiple sclerosis	7.09e-05	0.000304	CcSEcCtD
Mycophenolate mofetil—Discomfort—Dexamethasone—multiple sclerosis	7.09e-05	0.000304	CcSEcCtD
Mycophenolate mofetil—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	7.09e-05	0.000715	CbGpPWpGaD
Mycophenolate mofetil—Haemoglobin—Methotrexate—multiple sclerosis	7.09e-05	0.000304	CcSEcCtD
Mycophenolate mofetil—Hypotension—Methylprednisolone—multiple sclerosis	7.07e-05	0.000303	CcSEcCtD
Mycophenolate mofetil—Pain—Prednisolone—multiple sclerosis	7.05e-05	0.000302	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Methotrexate—multiple sclerosis	7.05e-05	0.000302	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Methotrexate—multiple sclerosis	7.05e-05	0.000302	CcSEcCtD
Mycophenolate mofetil—UGT2B7—Metabolism—SRM—multiple sclerosis	7.03e-05	0.000709	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—cerebellum—multiple sclerosis	7e-05	0.0052	CbGeAlD
Mycophenolate mofetil—Pharyngitis—Methotrexate—multiple sclerosis	7e-05	0.0003	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Methotrexate—multiple sclerosis	6.96e-05	0.000298	CcSEcCtD
Mycophenolate mofetil—UGT1A7—Metabolism—BCHE—multiple sclerosis	6.96e-05	0.000702	CbGpPWpGaD
Mycophenolate mofetil—Urethral disorder—Methotrexate—multiple sclerosis	6.91e-05	0.000296	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	6.91e-05	0.000296	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	6.9e-05	0.000295	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Dexamethasone—multiple sclerosis	6.88e-05	0.000295	CcSEcCtD
Mycophenolate mofetil—Oedema—Betamethasone—multiple sclerosis	6.88e-05	0.000295	CcSEcCtD
Mycophenolate mofetil—Oedema—Dexamethasone—multiple sclerosis	6.88e-05	0.000295	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Betamethasone—multiple sclerosis	6.88e-05	0.000295	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Mitoxantrone—multiple sclerosis	6.88e-05	0.000295	CcSEcCtD
Mycophenolate mofetil—UGT1A6—Metabolism—RRM1—multiple sclerosis	6.88e-05	0.000694	CbGpPWpGaD
Mycophenolate mofetil—Insomnia—Triamcinolone—multiple sclerosis	6.86e-05	0.000294	CcSEcCtD
Mycophenolate mofetil—ALB—Hemostasis—CD58—multiple sclerosis	6.85e-05	0.000692	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—SELPLG—multiple sclerosis	6.85e-05	0.000692	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—MERTK—multiple sclerosis	6.85e-05	0.000692	CbGpPWpGaD
Mycophenolate mofetil—Insomnia—Methylprednisolone—multiple sclerosis	6.85e-05	0.000293	CcSEcCtD
Mycophenolate mofetil—Infection—Dexamethasone—multiple sclerosis	6.84e-05	0.000293	CcSEcCtD
Mycophenolate mofetil—Infection—Betamethasone—multiple sclerosis	6.84e-05	0.000293	CcSEcCtD
Mycophenolate mofetil—ABCC2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.83e-05	0.000689	CbGpPWpGaD
Mycophenolate mofetil—Ill-defined disorder—Prednisone—multiple sclerosis	6.81e-05	0.000292	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Triamcinolone—multiple sclerosis	6.81e-05	0.000292	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Prednisolone—multiple sclerosis	6.8e-05	0.000291	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Methylprednisolone—multiple sclerosis	6.8e-05	0.000291	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Methotrexate—multiple sclerosis	6.79e-05	0.000291	CcSEcCtD
Mycophenolate mofetil—Anaemia—Prednisone—multiple sclerosis	6.79e-05	0.000291	CcSEcCtD
Mycophenolate mofetil—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	6.78e-05	0.000684	CbGpPWpGaD
Mycophenolate mofetil—Shock—Dexamethasone—multiple sclerosis	6.77e-05	0.00029	CcSEcCtD
Mycophenolate mofetil—Shock—Betamethasone—multiple sclerosis	6.77e-05	0.00029	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Triamcinolone—multiple sclerosis	6.76e-05	0.00029	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Dexamethasone—multiple sclerosis	6.75e-05	0.000289	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Betamethasone—multiple sclerosis	6.75e-05	0.000289	CcSEcCtD
Mycophenolate mofetil—Agitation—Prednisone—multiple sclerosis	6.75e-05	0.000289	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Dexamethasone—multiple sclerosis	6.74e-05	0.000289	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Betamethasone—multiple sclerosis	6.74e-05	0.000289	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Dexamethasone—multiple sclerosis	6.72e-05	0.000288	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Betamethasone—multiple sclerosis	6.72e-05	0.000288	CcSEcCtD
Mycophenolate mofetil—Angioedema—Prednisone—multiple sclerosis	6.71e-05	0.000287	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Triamcinolone—multiple sclerosis	6.68e-05	0.000286	CcSEcCtD
Mycophenolate mofetil—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.67e-05	0.000673	CbGpPWpGaD
Mycophenolate mofetil—Dyspepsia—Methylprednisolone—multiple sclerosis	6.66e-05	0.000285	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Dexamethasone—multiple sclerosis	6.65e-05	0.000285	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Betamethasone—multiple sclerosis	6.65e-05	0.000285	CcSEcCtD
Mycophenolate mofetil—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	6.65e-05	0.000671	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	6.65e-05	0.000671	CbGpPWpGaD
Mycophenolate mofetil—Malaise—Prednisone—multiple sclerosis	6.62e-05	0.000284	CcSEcCtD
Mycophenolate mofetil—Vertigo—Prednisone—multiple sclerosis	6.6e-05	0.000283	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Methotrexate—multiple sclerosis	6.59e-05	0.000282	CcSEcCtD
Mycophenolate mofetil—Syncope—Prednisone—multiple sclerosis	6.59e-05	0.000282	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Methotrexate—multiple sclerosis	6.57e-05	0.000282	CcSEcCtD
Mycophenolate mofetil—Anorexia—Betamethasone—multiple sclerosis	6.56e-05	0.000281	CcSEcCtD
Mycophenolate mofetil—Anorexia—Dexamethasone—multiple sclerosis	6.56e-05	0.000281	CcSEcCtD
Mycophenolate mofetil—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.56e-05	0.000662	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.56e-05	0.000662	CbGpPWpGaD
Mycophenolate mofetil—Urticaria—Prednisolone—multiple sclerosis	6.55e-05	0.000281	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Methotrexate—multiple sclerosis	6.54e-05	0.00028	CcSEcCtD
Mycophenolate mofetil—ABCB1—Allograft Rejection—CD86—multiple sclerosis	6.53e-05	0.000659	CbGpPWpGaD
Mycophenolate mofetil—ALB—Folate Metabolism—ICAM1—multiple sclerosis	6.52e-05	0.000658	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Biological oxidations—POMC—multiple sclerosis	6.51e-05	0.000657	CbGpPWpGaD
Mycophenolate mofetil—Pain—Triamcinolone—multiple sclerosis	6.49e-05	0.000278	CcSEcCtD
Mycophenolate mofetil—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.47e-05	0.000653	CbGpPWpGaD
Mycophenolate mofetil—Loss of consciousness—Prednisone—multiple sclerosis	6.46e-05	0.000277	CcSEcCtD
Mycophenolate mofetil—Hypotension—Dexamethasone—multiple sclerosis	6.43e-05	0.000276	CcSEcCtD
Mycophenolate mofetil—Hypotension—Betamethasone—multiple sclerosis	6.43e-05	0.000276	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.42e-05	0.000647	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—IL10—multiple sclerosis	6.4e-05	0.000646	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	6.4e-05	0.000646	CbGpPWpGaD
Mycophenolate mofetil—Angiopathy—Methotrexate—multiple sclerosis	6.4e-05	0.000274	CcSEcCtD
Mycophenolate mofetil—Vomiting—Mitoxantrone—multiple sclerosis	6.39e-05	0.000274	CcSEcCtD
Mycophenolate mofetil—IMPDH1—Metabolism—BCHE—multiple sclerosis	6.37e-05	0.000642	CbGpPWpGaD
Mycophenolate mofetil—Convulsion—Prednisone—multiple sclerosis	6.36e-05	0.000273	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Methotrexate—multiple sclerosis	6.35e-05	0.000272	CcSEcCtD
Mycophenolate mofetil—Hypertension—Prednisone—multiple sclerosis	6.34e-05	0.000272	CcSEcCtD
Mycophenolate mofetil—Rash—Mitoxantrone—multiple sclerosis	6.34e-05	0.000272	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Mitoxantrone—multiple sclerosis	6.33e-05	0.000271	CcSEcCtD
Mycophenolate mofetil—Chills—Methotrexate—multiple sclerosis	6.33e-05	0.000271	CcSEcCtD
Mycophenolate mofetil—Headache—Mitoxantrone—multiple sclerosis	6.3e-05	0.00027	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	6.27e-05	0.000269	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	6.27e-05	0.000269	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Prednisone—multiple sclerosis	6.25e-05	0.000268	CcSEcCtD
Mycophenolate mofetil—Myalgia—Prednisone—multiple sclerosis	6.25e-05	0.000268	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Triamcinolone—multiple sclerosis	6.25e-05	0.000268	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Methylprednisolone—multiple sclerosis	6.24e-05	0.000267	CcSEcCtD
Mycophenolate mofetil—Anxiety—Prednisone—multiple sclerosis	6.23e-05	0.000267	CcSEcCtD
Mycophenolate mofetil—Alopecia—Methotrexate—multiple sclerosis	6.23e-05	0.000267	CcSEcCtD
Mycophenolate mofetil—ABCB1—Allograft Rejection—IL4—multiple sclerosis	6.23e-05	0.000628	CbGpPWpGaD
Mycophenolate mofetil—Insomnia—Betamethasone—multiple sclerosis	6.23e-05	0.000267	CcSEcCtD
Mycophenolate mofetil—Insomnia—Dexamethasone—multiple sclerosis	6.23e-05	0.000267	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	6.21e-05	0.000266	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	6.19e-05	0.000265	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Betamethasone—multiple sclerosis	6.18e-05	0.000265	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Dexamethasone—multiple sclerosis	6.18e-05	0.000265	CcSEcCtD
Mycophenolate mofetil—Discomfort—Prednisone—multiple sclerosis	6.18e-05	0.000265	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Methotrexate—multiple sclerosis	6.18e-05	0.000265	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Methotrexate—multiple sclerosis	6.14e-05	0.000263	CcSEcCtD
Mycophenolate mofetil—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	6.1e-05	0.000615	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	6.09e-05	0.000614	CbGpPWpGaD
Mycophenolate mofetil—Hypersensitivity—Prednisolone—multiple sclerosis	6.08e-05	0.00026	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Dexamethasone—multiple sclerosis	6.06e-05	0.00026	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Betamethasone—multiple sclerosis	6.06e-05	0.00026	CcSEcCtD
Mycophenolate mofetil—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.06e-05	0.000611	CbGpPWpGaD
Mycophenolate mofetil—Urticaria—Triamcinolone—multiple sclerosis	6.03e-05	0.000258	CcSEcCtD
Mycophenolate mofetil—Urticaria—Methylprednisolone—multiple sclerosis	6.01e-05	0.000258	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Methotrexate—multiple sclerosis	6.01e-05	0.000257	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Triamcinolone—multiple sclerosis	6e-05	0.000257	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Prednisone—multiple sclerosis	5.99e-05	0.000257	CcSEcCtD
Mycophenolate mofetil—Oedema—Prednisone—multiple sclerosis	5.99e-05	0.000257	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Methylprednisolone—multiple sclerosis	5.98e-05	0.000256	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Betamethasone—multiple sclerosis	5.98e-05	0.000256	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Dexamethasone—multiple sclerosis	5.98e-05	0.000256	CcSEcCtD
Mycophenolate mofetil—Nausea—Mitoxantrone—multiple sclerosis	5.97e-05	0.000256	CcSEcCtD
Mycophenolate mofetil—Infection—Prednisone—multiple sclerosis	5.95e-05	0.000255	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	5.94e-05	0.000255	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Betamethasone—multiple sclerosis	5.94e-05	0.000255	CcSEcCtD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.94e-05	0.0006	CbGpPWpGaD
Mycophenolate mofetil—Back pain—Methotrexate—multiple sclerosis	5.94e-05	0.000254	CcSEcCtD
Mycophenolate mofetil—Shock—Prednisone—multiple sclerosis	5.9e-05	0.000253	CcSEcCtD
Mycophenolate mofetil—Pain—Betamethasone—multiple sclerosis	5.89e-05	0.000252	CcSEcCtD
Mycophenolate mofetil—Pain—Dexamethasone—multiple sclerosis	5.89e-05	0.000252	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Prednisone—multiple sclerosis	5.88e-05	0.000252	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Prednisone—multiple sclerosis	5.85e-05	0.000251	CcSEcCtD
Mycophenolate mofetil—ALB—Folate Metabolism—CCL2—multiple sclerosis	5.83e-05	0.000589	CbGpPWpGaD
Mycophenolate mofetil—Skin disorder—Prednisone—multiple sclerosis	5.82e-05	0.000249	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Prednisone—multiple sclerosis	5.79e-05	0.000248	CcSEcCtD
Mycophenolate mofetil—ABCB1—Allograft Rejection—FAS—multiple sclerosis	5.74e-05	0.000579	CbGpPWpGaD
Mycophenolate mofetil—Anorexia—Prednisone—multiple sclerosis	5.71e-05	0.000245	CcSEcCtD
Mycophenolate mofetil—UGT1A1—Metabolism—SRM—multiple sclerosis	5.71e-05	0.000576	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—SRM—multiple sclerosis	5.71e-05	0.000576	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	5.7e-05	0.000576	CbGpPWpGaD
Mycophenolate mofetil—Ill-defined disorder—Methotrexate—multiple sclerosis	5.69e-05	0.000244	CcSEcCtD
Mycophenolate mofetil—ABCB1—brain—multiple sclerosis	5.69e-05	0.00422	CbGeAlD
Mycophenolate mofetil—Anaemia—Methotrexate—multiple sclerosis	5.67e-05	0.000243	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Betamethasone—multiple sclerosis	5.67e-05	0.000243	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Dexamethasone—multiple sclerosis	5.67e-05	0.000243	CcSEcCtD
Mycophenolate mofetil—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	5.64e-05	0.000569	CbGpPWpGaD
Mycophenolate mofetil—Gastrointestinal pain—Betamethasone—multiple sclerosis	5.63e-05	0.000241	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Dexamethasone—multiple sclerosis	5.63e-05	0.000241	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Triamcinolone—multiple sclerosis	5.59e-05	0.000239	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Methylprednisolone—multiple sclerosis	5.58e-05	0.000239	CcSEcCtD
Mycophenolate mofetil—Malaise—Methotrexate—multiple sclerosis	5.54e-05	0.000237	CcSEcCtD
Mycophenolate mofetil—Vertigo—Methotrexate—multiple sclerosis	5.51e-05	0.000236	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Methotrexate—multiple sclerosis	5.49e-05	0.000235	CcSEcCtD
Mycophenolate mofetil—SLCO1B3—Metabolism—CYP24A1—multiple sclerosis	5.49e-05	0.000554	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—CYP27B1—multiple sclerosis	5.49e-05	0.000554	CbGpPWpGaD
Mycophenolate mofetil—Urticaria—Betamethasone—multiple sclerosis	5.47e-05	0.000234	CcSEcCtD
Mycophenolate mofetil—Urticaria—Dexamethasone—multiple sclerosis	5.47e-05	0.000234	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Prednisone—multiple sclerosis	5.46e-05	0.000234	CcSEcCtD
Mycophenolate mofetil—Dizziness—Prednisolone—multiple sclerosis	5.45e-05	0.000234	CcSEcCtD
Mycophenolate mofetil—Asthenia—Triamcinolone—multiple sclerosis	5.44e-05	0.000233	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Dexamethasone—multiple sclerosis	5.44e-05	0.000233	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Betamethasone—multiple sclerosis	5.44e-05	0.000233	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Dexamethasone—multiple sclerosis	5.44e-05	0.000233	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Betamethasone—multiple sclerosis	5.44e-05	0.000233	CcSEcCtD
Mycophenolate mofetil—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	5.44e-05	0.000549	CbGpPWpGaD
Mycophenolate mofetil—Asthenia—Methylprednisolone—multiple sclerosis	5.43e-05	0.000233	CcSEcCtD
Mycophenolate mofetil—Insomnia—Prednisone—multiple sclerosis	5.42e-05	0.000232	CcSEcCtD
Mycophenolate mofetil—UGT1A8—Metabolism—BCHE—multiple sclerosis	5.41e-05	0.000546	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.4e-05	0.000545	CbGpPWpGaD
Mycophenolate mofetil—Paraesthesia—Prednisone—multiple sclerosis	5.38e-05	0.000231	CcSEcCtD
Mycophenolate mofetil—Pruritus—Triamcinolone—multiple sclerosis	5.37e-05	0.00023	CcSEcCtD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.36e-05	0.000541	CbGpPWpGaD
Mycophenolate mofetil—Cough—Methotrexate—multiple sclerosis	5.36e-05	0.000229	CcSEcCtD
Mycophenolate mofetil—Pruritus—Methylprednisolone—multiple sclerosis	5.35e-05	0.000229	CcSEcCtD
Mycophenolate mofetil—Convulsion—Methotrexate—multiple sclerosis	5.32e-05	0.000228	CcSEcCtD
Mycophenolate mofetil—UGT1A1—Biological oxidations—POMC—multiple sclerosis	5.29e-05	0.000534	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Biological oxidations—POMC—multiple sclerosis	5.29e-05	0.000534	CbGpPWpGaD
Mycophenolate mofetil—Dyspepsia—Prednisone—multiple sclerosis	5.28e-05	0.000226	CcSEcCtD
Mycophenolate mofetil—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.25e-05	0.000529	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—SRM—multiple sclerosis	5.23e-05	0.000528	CbGpPWpGaD
Mycophenolate mofetil—Arthralgia—Methotrexate—multiple sclerosis	5.23e-05	0.000224	CcSEcCtD
Mycophenolate mofetil—Chest pain—Methotrexate—multiple sclerosis	5.23e-05	0.000224	CcSEcCtD
Mycophenolate mofetil—Myalgia—Methotrexate—multiple sclerosis	5.23e-05	0.000224	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Prednisone—multiple sclerosis	5.21e-05	0.000223	CcSEcCtD
Mycophenolate mofetil—Rash—Prednisolone—multiple sclerosis	5.2e-05	0.000223	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Prednisolone—multiple sclerosis	5.2e-05	0.000223	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	5.19e-05	0.000222	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Methylprednisolone—multiple sclerosis	5.18e-05	0.000222	CcSEcCtD
Mycophenolate mofetil—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	5.18e-05	0.000523	CbGpPWpGaD
Mycophenolate mofetil—Headache—Prednisolone—multiple sclerosis	5.17e-05	0.000221	CcSEcCtD
Mycophenolate mofetil—Discomfort—Methotrexate—multiple sclerosis	5.16e-05	0.000221	CcSEcCtD
Mycophenolate mofetil—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	5.15e-05	0.00052	CbGpPWpGaD
Mycophenolate mofetil—Constipation—Prednisone—multiple sclerosis	5.13e-05	0.00022	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.07e-05	0.000512	CbGpPWpGaD
Mycophenolate mofetil—Confusional state—Methotrexate—multiple sclerosis	5.05e-05	0.000216	CcSEcCtD
Mycophenolate mofetil—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	5.04e-05	0.000509	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—GPC5—multiple sclerosis	5.02e-05	0.000506	CbGpPWpGaD
Mycophenolate mofetil—Dizziness—Triamcinolone—multiple sclerosis	5.02e-05	0.000215	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Methotrexate—multiple sclerosis	5.01e-05	0.000215	CcSEcCtD
Mycophenolate mofetil—Dizziness—Methylprednisolone—multiple sclerosis	5e-05	0.000214	CcSEcCtD
Mycophenolate mofetil—Infection—Methotrexate—multiple sclerosis	4.98e-05	0.000213	CcSEcCtD
Mycophenolate mofetil—ALB—Folate Metabolism—IFNG—multiple sclerosis	4.96e-05	0.0005	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—CYP24A1—multiple sclerosis	4.95e-05	0.0005	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—CYP27B1—multiple sclerosis	4.95e-05	0.0005	CbGpPWpGaD
Mycophenolate mofetil—Feeling abnormal—Prednisone—multiple sclerosis	4.94e-05	0.000212	CcSEcCtD
Mycophenolate mofetil—Asthenia—Dexamethasone—multiple sclerosis	4.94e-05	0.000212	CcSEcCtD
Mycophenolate mofetil—Asthenia—Betamethasone—multiple sclerosis	4.94e-05	0.000212	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Methotrexate—multiple sclerosis	4.91e-05	0.00021	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Methotrexate—multiple sclerosis	4.9e-05	0.00021	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Prednisone—multiple sclerosis	4.9e-05	0.00021	CcSEcCtD
Mycophenolate mofetil—Nausea—Prednisolone—multiple sclerosis	4.9e-05	0.00021	CcSEcCtD
Mycophenolate mofetil—Pruritus—Dexamethasone—multiple sclerosis	4.87e-05	0.000209	CcSEcCtD
Mycophenolate mofetil—Pruritus—Betamethasone—multiple sclerosis	4.87e-05	0.000209	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Methotrexate—multiple sclerosis	4.87e-05	0.000208	CcSEcCtD
Mycophenolate mofetil—ABCG2—Metabolism—SRM—multiple sclerosis	4.84e-05	0.000489	CbGpPWpGaD
Mycophenolate mofetil—Hyperhidrosis—Methotrexate—multiple sclerosis	4.84e-05	0.000207	CcSEcCtD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.84e-05	0.000488	CbGpPWpGaD
Mycophenolate mofetil—Vomiting—Triamcinolone—multiple sclerosis	4.82e-05	0.000207	CcSEcCtD
Mycophenolate mofetil—Vomiting—Methylprednisolone—multiple sclerosis	4.81e-05	0.000206	CcSEcCtD
Mycophenolate mofetil—Rash—Triamcinolone—multiple sclerosis	4.78e-05	0.000205	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Triamcinolone—multiple sclerosis	4.78e-05	0.000205	CcSEcCtD
Mycophenolate mofetil—Anorexia—Methotrexate—multiple sclerosis	4.77e-05	0.000205	CcSEcCtD
Mycophenolate mofetil—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.77e-05	0.000482	CbGpPWpGaD
Mycophenolate mofetil—Rash—Methylprednisolone—multiple sclerosis	4.77e-05	0.000204	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Methylprednisolone—multiple sclerosis	4.77e-05	0.000204	CcSEcCtD
Mycophenolate mofetil—Urticaria—Prednisone—multiple sclerosis	4.76e-05	0.000204	CcSEcCtD
Mycophenolate mofetil—ABCB1—Allograft Rejection—CD80—multiple sclerosis	4.76e-05	0.00048	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.76e-05	0.00048	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.76e-05	0.00048	CbGpPWpGaD
Mycophenolate mofetil—Headache—Triamcinolone—multiple sclerosis	4.75e-05	0.000204	CcSEcCtD
Mycophenolate mofetil—Headache—Methylprednisolone—multiple sclerosis	4.74e-05	0.000203	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Prednisone—multiple sclerosis	4.74e-05	0.000203	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Prednisone—multiple sclerosis	4.74e-05	0.000203	CcSEcCtD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.73e-05	0.000477	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.73e-05	0.000477	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.73e-05	0.000477	CbGpPWpGaD
Mycophenolate mofetil—Diarrhoea—Dexamethasone—multiple sclerosis	4.71e-05	0.000202	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Betamethasone—multiple sclerosis	4.71e-05	0.000202	CcSEcCtD
Mycophenolate mofetil—IMPDH2—Metabolism—APOE—multiple sclerosis	4.7e-05	0.000474	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.7e-05	0.000474	CbGpPWpGaD
Mycophenolate mofetil—Hypotension—Methotrexate—multiple sclerosis	4.68e-05	0.000201	CcSEcCtD
Mycophenolate mofetil—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	4.63e-05	0.000468	CbGpPWpGaD
Mycophenolate mofetil—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	4.56e-05	0.000196	CcSEcCtD
Mycophenolate mofetil—Dizziness—Dexamethasone—multiple sclerosis	4.55e-05	0.000195	CcSEcCtD
Mycophenolate mofetil—Dizziness—Betamethasone—multiple sclerosis	4.55e-05	0.000195	CcSEcCtD
Mycophenolate mofetil—Insomnia—Methotrexate—multiple sclerosis	4.53e-05	0.000194	CcSEcCtD
Mycophenolate mofetil—UGT2B7—Metabolism—GPC5—multiple sclerosis	4.53e-05	0.000457	CbGpPWpGaD
Mycophenolate mofetil—Nausea—Triamcinolone—multiple sclerosis	4.51e-05	0.000193	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Methotrexate—multiple sclerosis	4.5e-05	0.000193	CcSEcCtD
Mycophenolate mofetil—Nausea—Methylprednisolone—multiple sclerosis	4.5e-05	0.000193	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.48e-05	0.000452	CbGpPWpGaD
Mycophenolate mofetil—Dyspnoea—Methotrexate—multiple sclerosis	4.47e-05	0.000191	CcSEcCtD
Mycophenolate mofetil—Somnolence—Methotrexate—multiple sclerosis	4.45e-05	0.000191	CcSEcCtD
Mycophenolate mofetil—ALB—Folate Metabolism—IL1B—multiple sclerosis	4.42e-05	0.000446	CbGpPWpGaD
Mycophenolate mofetil—Hypersensitivity—Prednisone—multiple sclerosis	4.42e-05	0.000189	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Methotrexate—multiple sclerosis	4.41e-05	0.000189	CcSEcCtD
Mycophenolate mofetil—ALB—Folate Metabolism—IL2—multiple sclerosis	4.41e-05	0.000445	CbGpPWpGaD
Mycophenolate mofetil—Vomiting—Dexamethasone—multiple sclerosis	4.38e-05	0.000187	CcSEcCtD
Mycophenolate mofetil—Vomiting—Betamethasone—multiple sclerosis	4.38e-05	0.000187	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Methotrexate—multiple sclerosis	4.35e-05	0.000187	CcSEcCtD
Mycophenolate mofetil—Rash—Betamethasone—multiple sclerosis	4.34e-05	0.000186	CcSEcCtD
Mycophenolate mofetil—Rash—Dexamethasone—multiple sclerosis	4.34e-05	0.000186	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Betamethasone—multiple sclerosis	4.34e-05	0.000186	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Dexamethasone—multiple sclerosis	4.34e-05	0.000186	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Methotrexate—multiple sclerosis	4.32e-05	0.000185	CcSEcCtD
Mycophenolate mofetil—Headache—Betamethasone—multiple sclerosis	4.31e-05	0.000185	CcSEcCtD
Mycophenolate mofetil—Headache—Dexamethasone—multiple sclerosis	4.31e-05	0.000185	CcSEcCtD
Mycophenolate mofetil—Asthenia—Prednisone—multiple sclerosis	4.3e-05	0.000184	CcSEcCtD
Mycophenolate mofetil—Pain—Methotrexate—multiple sclerosis	4.28e-05	0.000184	CcSEcCtD
Mycophenolate mofetil—UGT2B7—NRF2 pathway—TGFB1—multiple sclerosis	4.28e-05	0.000432	CbGpPWpGaD
Mycophenolate mofetil—Pruritus—Prednisone—multiple sclerosis	4.24e-05	0.000182	CcSEcCtD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.24e-05	0.000428	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PLEK—multiple sclerosis	4.23e-05	0.000427	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—APOE—multiple sclerosis	4.19e-05	0.000423	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—RRM1—multiple sclerosis	4.16e-05	0.00042	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.15e-05	0.000419	CbGpPWpGaD
Mycophenolate mofetil—Feeling abnormal—Methotrexate—multiple sclerosis	4.13e-05	0.000177	CcSEcCtD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	4.12e-05	0.000416	CbGpPWpGaD
Mycophenolate mofetil—Diarrhoea—Prednisone—multiple sclerosis	4.1e-05	0.000176	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Methotrexate—multiple sclerosis	4.1e-05	0.000175	CcSEcCtD
Mycophenolate mofetil—Nausea—Betamethasone—multiple sclerosis	4.09e-05	0.000175	CcSEcCtD
Mycophenolate mofetil—Nausea—Dexamethasone—multiple sclerosis	4.09e-05	0.000175	CcSEcCtD
Mycophenolate mofetil—IMPDH2—Metabolism—POMC—multiple sclerosis	4.04e-05	0.000407	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CYP27B1—multiple sclerosis	4.02e-05	0.000406	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CYP24A1—multiple sclerosis	4.02e-05	0.000406	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CYP24A1—multiple sclerosis	4.02e-05	0.000406	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CYP27B1—multiple sclerosis	4.02e-05	0.000406	CbGpPWpGaD
Mycophenolate mofetil—Urticaria—Methotrexate—multiple sclerosis	3.98e-05	0.00017	CcSEcCtD
Mycophenolate mofetil—Dizziness—Prednisone—multiple sclerosis	3.96e-05	0.00017	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Methotrexate—multiple sclerosis	3.96e-05	0.00017	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Methotrexate—multiple sclerosis	3.96e-05	0.00017	CcSEcCtD
Mycophenolate mofetil—UGT1A6—Metabolism—BCHE—multiple sclerosis	3.95e-05	0.000398	CbGpPWpGaD
Mycophenolate mofetil—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	3.95e-05	0.000398	CbGpPWpGaD
Mycophenolate mofetil—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	3.94e-05	0.000398	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.93e-05	0.000397	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	3.83e-05	0.000387	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—APOE—multiple sclerosis	3.83e-05	0.000386	CbGpPWpGaD
Mycophenolate mofetil—Vomiting—Prednisone—multiple sclerosis	3.81e-05	0.000163	CcSEcCtD
Mycophenolate mofetil—Rash—Prednisone—multiple sclerosis	3.78e-05	0.000162	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Prednisone—multiple sclerosis	3.78e-05	0.000162	CcSEcCtD
Mycophenolate mofetil—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	3.76e-05	0.00038	CbGpPWpGaD
Mycophenolate mofetil—Headache—Prednisone—multiple sclerosis	3.75e-05	0.000161	CcSEcCtD
Mycophenolate mofetil—UGT2B7—Metabolism—RRM1—multiple sclerosis	3.75e-05	0.000379	CbGpPWpGaD
Mycophenolate mofetil—Hypersensitivity—Methotrexate—multiple sclerosis	3.69e-05	0.000158	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Metabolism—CYP27B1—multiple sclerosis	3.69e-05	0.000372	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CYP24A1—multiple sclerosis	3.69e-05	0.000372	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—GPC5—multiple sclerosis	3.68e-05	0.000371	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—GPC5—multiple sclerosis	3.68e-05	0.000371	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—ALB—multiple sclerosis	3.68e-05	0.000371	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.67e-05	0.00037	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.6e-05	0.000364	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—POMC—multiple sclerosis	3.6e-05	0.000363	CbGpPWpGaD
Mycophenolate mofetil—Asthenia—Methotrexate—multiple sclerosis	3.59e-05	0.000154	CcSEcCtD
Mycophenolate mofetil—Nausea—Prednisone—multiple sclerosis	3.56e-05	0.000153	CcSEcCtD
Mycophenolate mofetil—Pruritus—Methotrexate—multiple sclerosis	3.54e-05	0.000152	CcSEcCtD
Mycophenolate mofetil—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	3.51e-05	0.000355	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—NRF2 pathway—TGFB1—multiple sclerosis	3.48e-05	0.000351	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—NRF2 pathway—TGFB1—multiple sclerosis	3.48e-05	0.000351	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.47e-05	0.00035	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—SRM—multiple sclerosis	3.47e-05	0.00035	CbGpPWpGaD
Mycophenolate mofetil—Diarrhoea—Methotrexate—multiple sclerosis	3.43e-05	0.000147	CcSEcCtD
Mycophenolate mofetil—ABCG2—Metabolism—CYP24A1—multiple sclerosis	3.41e-05	0.000344	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CYP27B1—multiple sclerosis	3.41e-05	0.000344	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	3.39e-05	0.000343	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—GPC5—multiple sclerosis	3.37e-05	0.00034	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	3.36e-05	0.000339	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—IL2—multiple sclerosis	3.34e-05	0.000337	CbGpPWpGaD
Mycophenolate mofetil—Dizziness—Methotrexate—multiple sclerosis	3.31e-05	0.000142	CcSEcCtD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.31e-05	0.000334	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—POMC—multiple sclerosis	3.29e-05	0.000332	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—ALB—multiple sclerosis	3.28e-05	0.000331	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—APOE—multiple sclerosis	3.26e-05	0.000329	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.23e-05	0.000326	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Biological oxidations—POMC—multiple sclerosis	3.22e-05	0.000325	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.21e-05	0.000324	CbGpPWpGaD
Mycophenolate mofetil—ALB—Folate Metabolism—TNF—multiple sclerosis	3.21e-05	0.000324	CbGpPWpGaD
Mycophenolate mofetil—Vomiting—Methotrexate—multiple sclerosis	3.18e-05	0.000136	CcSEcCtD
Mycophenolate mofetil—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	3.18e-05	0.000321	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.18e-05	0.000321	CbGpPWpGaD
Mycophenolate mofetil—Rash—Methotrexate—multiple sclerosis	3.16e-05	0.000135	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Methotrexate—multiple sclerosis	3.16e-05	0.000135	CcSEcCtD
Mycophenolate mofetil—Headache—Methotrexate—multiple sclerosis	3.14e-05	0.000134	CcSEcCtD
Mycophenolate mofetil—ABCG2—Metabolism—GPC5—multiple sclerosis	3.12e-05	0.000315	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—RRM1—multiple sclerosis	3.05e-05	0.000308	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—RRM1—multiple sclerosis	3.05e-05	0.000308	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—SRM—multiple sclerosis	3.01e-05	0.000303	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—ALB—multiple sclerosis	3e-05	0.000303	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—SRM—multiple sclerosis	2.99e-05	0.000302	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—SELE—multiple sclerosis	2.98e-05	0.000301	CbGpPWpGaD
Mycophenolate mofetil—Nausea—Methotrexate—multiple sclerosis	2.98e-05	0.000127	CcSEcCtD
Mycophenolate mofetil—ALB—Platelet degranulation—TGFB1—multiple sclerosis	2.95e-05	0.000297	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.9e-05	0.000292	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	2.86e-05	0.000289	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.83e-05	0.000286	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.82e-05	0.000284	CbGpPWpGaD
Mycophenolate mofetil—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	2.81e-05	0.000283	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—POMC—multiple sclerosis	2.8e-05	0.000282	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—RRM1—multiple sclerosis	2.79e-05	0.000282	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Biological oxidations—POMC—multiple sclerosis	2.79e-05	0.000281	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.77e-05	0.00028	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—SRM—multiple sclerosis	2.62e-05	0.000264	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.61e-05	0.000263	CbGpPWpGaD
Mycophenolate mofetil—ALB—Folate Metabolism—IL6—multiple sclerosis	2.59e-05	0.000261	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—RRM1—multiple sclerosis	2.59e-05	0.000261	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.56e-05	0.000259	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—ALB—multiple sclerosis	2.55e-05	0.000257	CbGpPWpGaD
Mycophenolate mofetil—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	2.55e-05	0.000257	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.54e-05	0.000256	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.53e-05	0.000255	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	2.45e-05	0.000247	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	2.45e-05	0.000247	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.44e-05	0.000246	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.4e-05	0.000242	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—BCHE—multiple sclerosis	2.39e-05	0.000241	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—APOE—multiple sclerosis	2.38e-05	0.00024	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.37e-05	0.000239	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.24e-05	0.000226	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GPC5—multiple sclerosis	2.24e-05	0.000226	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.17e-05	0.000219	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—ITGA4—multiple sclerosis	2.16e-05	0.000218	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—BCHE—multiple sclerosis	2.15e-05	0.000217	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—IFNB1—multiple sclerosis	2.14e-05	0.000216	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	2.12e-05	0.000214	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	2.12e-05	0.000214	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP27B1—multiple sclerosis	2.11e-05	0.000213	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP24A1—multiple sclerosis	2.11e-05	0.000213	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.07e-05	0.000209	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.06e-05	0.000208	CbGpPWpGaD
Mycophenolate mofetil—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	2.06e-05	0.000208	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—POMC—multiple sclerosis	2.04e-05	0.000206	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.03e-05	0.000205	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.94e-05	0.000196	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GPC5—multiple sclerosis	1.93e-05	0.000194	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.86e-05	0.000188	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—ALB—multiple sclerosis	1.86e-05	0.000188	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—RRM1—multiple sclerosis	1.85e-05	0.000187	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.85e-05	0.000187	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.85e-05	0.000186	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.85e-05	0.000186	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—BCHE—multiple sclerosis	1.75e-05	0.000177	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—BCHE—multiple sclerosis	1.75e-05	0.000177	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.72e-05	0.000173	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.7e-05	0.000171	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GPC5—multiple sclerosis	1.69e-05	0.00017	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.68e-05	0.000169	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.61e-05	0.000163	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SRM—multiple sclerosis	1.61e-05	0.000163	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.61e-05	0.000162	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—BCHE—multiple sclerosis	1.6e-05	0.000162	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—RRM1—multiple sclerosis	1.6e-05	0.000161	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.5e-05	0.000151	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.49e-05	0.000151	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—BCHE—multiple sclerosis	1.49e-05	0.00015	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—IL2RA—multiple sclerosis	1.47e-05	0.000149	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—APOE—multiple sclerosis	1.44e-05	0.000145	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—RRM1—multiple sclerosis	1.4e-05	0.000141	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.31e-05	0.000132	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—APOE—multiple sclerosis	1.3e-05	0.000131	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.29e-05	0.00013	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.29e-05	0.00013	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.28e-05	0.000129	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.26e-05	0.000127	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.25e-05	0.000126	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.24e-05	0.000125	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—POMC—multiple sclerosis	1.23e-05	0.000125	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.2e-05	0.000121	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.14e-05	0.000115	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.14e-05	0.000115	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—ALB—multiple sclerosis	1.13e-05	0.000114	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—POMC—multiple sclerosis	1.11e-05	0.000112	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.07e-05	0.000108	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.06e-05	0.000107	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.06e-05	0.000107	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—APOE—multiple sclerosis	1.05e-05	0.000106	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—APOE—multiple sclerosis	1.05e-05	0.000106	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.04e-05	0.000105	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—ALB—multiple sclerosis	1.02e-05	0.000102	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.75e-06	9.84e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—APOE—multiple sclerosis	9.65e-06	9.74e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—BCHE—multiple sclerosis	9.22e-06	9.3e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—BCHE—multiple sclerosis	9.17e-06	9.25e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—POMC—multiple sclerosis	9.05e-06	9.13e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—POMC—multiple sclerosis	9.05e-06	9.13e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—APOE—multiple sclerosis	8.94e-06	9.02e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—IL2—multiple sclerosis	8.64e-06	8.72e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—RRM1—multiple sclerosis	8.62e-06	8.7e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—POMC—multiple sclerosis	8.29e-06	8.37e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—ALB—multiple sclerosis	8.25e-06	8.33e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—ALB—multiple sclerosis	8.25e-06	8.33e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.08e-06	8.15e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—BCHE—multiple sclerosis	8.03e-06	8.11e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—POMC—multiple sclerosis	7.68e-06	7.75e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—ALB—multiple sclerosis	7.56e-06	7.63e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ALB—multiple sclerosis	7e-06	7.06e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—TGFB1—multiple sclerosis	6.74e-06	6.8e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—MAPK1—multiple sclerosis	6.61e-06	6.67e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—APOE—multiple sclerosis	6.4e-06	6.46e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—APOE—multiple sclerosis	5.55e-06	5.6e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—APOE—multiple sclerosis	5.52e-06	5.57e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—POMC—multiple sclerosis	5.5e-06	5.55e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ALB—multiple sclerosis	5.02e-06	5.06e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—BCHE—multiple sclerosis	4.95e-06	4.99e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—APOE—multiple sclerosis	4.83e-06	4.88e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—POMC—multiple sclerosis	4.77e-06	4.81e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—POMC—multiple sclerosis	4.74e-06	4.78e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ALB—multiple sclerosis	4.34e-06	4.38e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—POMC—multiple sclerosis	4.15e-06	4.19e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ALB—multiple sclerosis	3.78e-06	3.82e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—APOE—multiple sclerosis	2.98e-06	3e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—POMC—multiple sclerosis	2.56e-06	2.58e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ALB—multiple sclerosis	2.33e-06	2.35e-05	CbGpPWpGaD
